Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Pathol Res Pract ; 256: 155266, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38554489

RESUMO

Hepatic tumors present a formidable challenge in cancer therapeutics, necessitating the exploration of novel treatment strategies. In recent years, targeting the immune system has attracted interest to augment existing therapeutic efficacy. The immune system in hepatic tumors includes numerous cells with diverse actions. CD8+ T lymphocytes, T helper 1 (Th1) CD4+ T lymphocytes, alternative M1 macrophages, and natural killer (NK) cells provide the antitumor immunity. However, Foxp3+ regulatory CD4+ T cells (Tregs), M2-like tumor-associated macrophages (TAMs), and myeloid-derived suppressor cells (MDSCs) are the key immune inhibitor cells. Tumor stroma can also affect these interactions. Targeting these cells and their secreted molecules is intriguing for eliminating malignant cells. The current review provides a synopsis of the immune system components involved in hepatic tumor expansion and highlights the molecular and cellular pathways that can be targeted for therapeutic intervention. It also overviews the diverse range of drugs, natural products, immunotherapy drugs, and nanoparticles that have been investigated to manipulate immune responses and bolster antitumor immunity. The review also addresses the potential advantages and challenges associated with these approaches.


Assuntos
Produtos Biológicos , Neoplasias Hepáticas , Nanopartículas , Neoplasias , Humanos , Produtos Biológicos/uso terapêutico , Produtos Biológicos/metabolismo , Neoplasias/patologia , Imunoterapia , Macrófagos/patologia , Neoplasias Hepáticas/patologia , Nanopartículas/uso terapêutico , Microambiente Tumoral
2.
Chem Biodivers ; 21(5): e202400366, 2024 May.
Artigo em Inglês | MEDLINE | ID: mdl-38498805

RESUMO

The escalating global health challenge posed by infections prompts the exploration of innovative solutions utilizing MXene-based nanostructures. Societally, the need for effective antimicrobial strategies is crucial for public health, while scientifically, MXenes present promising properties for therapeutic applications, necessitating scalable production and comprehensive characterization techniques. Here we review the versatile physicochemical properties of MXene materials for combatting microbial threats and their various synthesis methods, including etching and top-down or bottom-up techniques. Crucial characterization techniques such as XRD, Raman spectroscopy, SEM/TEM, FTIR, XPS, and BET analysis provide insightful structural and functional attributes. The review highlights MXenes' diverse antimicrobial mechanisms, spanning membrane disruption and oxidative stress induction, demonstrating efficacy against bacterial, viral, and fungal infections. Despite translational hurdles, MXene-based nanostructures offer broad-spectrum antimicrobial potential, with applications in drug delivery and diagnostics, presenting a promising path for advancing infection control in global healthcare.


Assuntos
Anti-Infecciosos , Nanoestruturas , Nanoestruturas/química , Anti-Infecciosos/farmacologia , Anti-Infecciosos/química , Anti-Infecciosos/síntese química , Humanos , Testes de Sensibilidade Microbiana , Bactérias/efeitos dos fármacos , Controle de Infecções , Antibacterianos/farmacologia , Antibacterianos/química , Antibacterianos/síntese química
3.
Naunyn Schmiedebergs Arch Pharmacol ; 397(8): 5463-5481, 2024 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-38459989

RESUMO

This review paper provides an in-depth analysis of the significance of lipid nanocarriers in drug delivery and the crucial role of characterization techniques. It explores various types of lipid nanocarriers and their applications, emphasizing the importance of microscopy-based characterization methods such as light microscopy, confocal microscopy, transmission electron microscopy (TEM), scanning electron microscopy (SEM), and atomic force microscopy (AFM). The paper also delves into sample preparation, quantitative analysis, challenges, and future directions in the field. The review concludes by underlining the pivotal role of microscopy-based characterization in advancing lipid nanocarrier research and drug delivery technologies.


Assuntos
Portadores de Fármacos , Sistemas de Liberação de Medicamentos , Lipídeos , Nanopartículas , Portadores de Fármacos/química , Lipídeos/química , Humanos , Animais , Microscopia/métodos , Microscopia de Força Atômica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA